Opportunity ID: 333052

General Information

Document Type: Grants Notice
Funding Opportunity Number: HRSA-21-110
Funding Opportunity Title: Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO-RGN)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation: https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=7d831f34-ff58-41d1-9ec1-37b9481c2a62
Expected Number of Awards: 3
Assistance Listings: 93.110 — Maternal and Child Health Federal Consolidated Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 22, 2021
Last Updated Date: Apr 22, 2021
Original Closing Date for Applications: Jun 07, 2021
Current Closing Date for Applications: Jun 07, 2021
Archive Date: Aug 06, 2021
Estimated Total Program Funding: $495,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible applicants are current recipients who are currently receiving funding under HRSA-20-046 Regional Genetics Network program.

Additional Information

Agency Name: Health Resources and Services Administration
Description: This notice announces the opportunity to apply for supplemental funding under the Regional Genetics Networks (RGN) program (HRSA-20-046). The purpose of this Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Network (EGGMIO-RGN) project is to evaluate the implementation and outcomes of selected RGN program activities aimed to improve access to services for individuals with, or at risk for, genetic or genomic conditions1 and their families, especially those among underserved populations. This evaluation will be used to inform the RGN recipients and the field of genetic and genomic medicine with best practices and strategies to implement genetic and genomic advances into clinical and public health.
HRSA will fund up to three awards, and each RGN recipient will plan and conduct a focused, rigorous evaluation of implementation and/or outcomes of one or more of their program activities to study their utility, applicability, and effectiveness. The evaluation should focus on one or more strategies the RGN is implementing to meet the goals of the RGN program and not a new activity. Example topics of interest include, but are not limited to, evaluating:
• Strategies to outreach and engage primary care providers and non-geneticists to provide additional resources, education, or training to improve their ability to use genomics for the care of their patients.
• Perceived clinical utility by providers or individuals and families of RGN-developed genetic or genomic resource(s) throughout the lifecycle of diagnosis, treatment, and management.
• Implementation and clinical outcomes of RGN-supported genetic or genomic services offered through nontraditional modalities, such as telehealth.
• Applicability of RGN developed resources or strategies across regions and subsequent dissemination of lessons learned across the regions. Examples include adaptation of a strategy through multi-RGN collaboration to address unmet needs common across regions or expanding implementation of the strategy to multiple regions.
• Impact of integrating the latest scientific evidence relevant to the genetic or genomic condition to improve the utility, applicability and/or effectiveness of the RGN program activity.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Department of Health and Human Services, Health Resources and Services Administration
skim@hrsa.gov
Email:skim@hrsa.gov

Version History

Version Modification Description Updated Date

Folder 333052 Full Announcement-HRSA-21-110 -> MCHB HRSA-21-110 (UH7) RGN_Final.pdf

Packages

Agency Contact Information: Department of Health and Human Services, Health Resources and Services Administration
skim@hrsa.gov
Email: skim@hrsa.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.110 HRSA-21-110 Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO-RGN) PKG00266691 Apr 22, 2021 Jun 07, 2021 View

Package 1

Mandatory forms

333052 SF424_2_1-2.1.pdf

333052 AttachmentForm_1_2-1.2.pdf

333052 PerformanceSite_2_0-2.0.pdf

333052 ProjectNarrativeAttachments_1_2-1.2.pdf

333052 GG_LobbyingForm-1.1.pdf

333052 BudgetNarrativeAttachments_1_2-1.2.pdf

333052 SF424A-1.0.pdf

Optional forms

333052 SFLLL_1_2-1.2.pdf

2025-07-09T22:10:47-05:00

Share This Post, Choose Your Platform!

About the Author: